WallStreetZenWallStreetZen

NASDAQ: PSTX
Poseida Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PSTX past revenue growth

How has PSTX's revenue growth performed historically?
Company
-50.42%
Industry
149.51%
Market
17.15%
PSTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PSTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

PSTX earnings and revenue history

Current Revenue
$64.7M
Current Earnings
-$123.4M
Current Profit Margin
-190.8%

PSTX Return on Equity

Current Company
-94.9%
Current Industry
-63.5%
Current Market
188%
PSTX's Return on Equity (-94.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PSTX announces earnings.

PSTX Return on Assets

Current Company
-42.2%
Current Industry
2.9%
PSTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PSTX Return on Capital Employed

Current Company
-56.6%
Current Industry
19.5%
PSTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PSTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PSTX$64.70M-$109.04M-$123.43M+43.92%N/A
CRDF$488.00k-$41.04M-$41.47M+5.22%N/A
TRVI$0.00-$28.58M-$29.07MN/AN/A
ZVRA$27.46M-$43.54M-$46.05M+20.93%N/A
IPHA$67.00M-$700.00k-$8.23M-8.70%N/A
View Top Biotech Stocks

PSTX earnings dates

Next earnings date
May 7, 2024

Poseida Therapeutics Earnings & Revenue FAQ

What were PSTX's earnings last quarter?

On Invalid Date, Poseida Therapeutics (NASDAQ: PSTX) reported Q4 2023 earnings per share (EPS) of -$0.26, up 39.53% year over year. Total Poseida Therapeutics earnings for the quarter were -$25.35 million. In the same quarter last year, Poseida Therapeutics's earnings per share (EPS) was -$0.43.

If you're new to stock investing, here's how to buy Poseida Therapeutics stock.

What was PSTX's earnings growth in the past year?

As of Q2 2024, Poseida Therapeutics's earnings has grown year over year. Poseida Therapeutics's earnings in the past year totalled -$123.43 million.

What is PSTX's earnings date?

Poseida Therapeutics's earnings date is Invalid Date. Add PSTX to your watchlist to be reminded of PSTX's next earnings announcement.

What was PSTX's revenue last quarter?

On Invalid Date, Poseida Therapeutics (NASDAQ: PSTX) reported Q4 2023 revenue of $25.00 million up 148.68% year over year. In the same quarter last year, Poseida Therapeutics's revenue was $10.05 million.

What was PSTX's revenue growth in the past year?

As of Q2 2024, Poseida Therapeutics's revenue has grown -50.42% year over year. This is 199.93 percentage points lower than the US Biotechnology industry revenue growth rate of 149.51%. Poseida Therapeutics's revenue in the past year totalled $64.70 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.